CRANBURY, N.J.--(BUSINESS WIRE)--OncLive® mourns the loss of Jimmie Holland, M.D., who passed away at age 89 on Dec. 24, 2017. Dr. Holland was a 2014 Giants of Cancer Care® Inductee, a member of the 2016 and 2017 Giants selection committee and was the founder of psycho-oncology. She will be remembered for her groundbreaking work to combat the traumatizing psychological impact of cancer diagnosis on patients.
“We are deeply saddened by Dr. Holland’s passing,” said Michael J. Hennessy, Jr., president, Michael J. Hennessy Associates, parent company of OncLive®. “Her contributions helped shape the field of psycho-oncology and offered patients a revolutionary way to cope with the stress that is experienced with cancer. The legacy she leaves behind will continue to inspire us and many others through generations.”
In 1977, Dr. Holland created a full-time Psychiatry Service at Memorial Sloan Kettering where she served as a Chief until 1996. Following her role as Chief, she served as a chairperson for the Department of Psychiatry until 2003. During her 40-year career, Dr. Holland offered revolutionary contributions to the field of psycho-oncology. She played an instrumental role in gaining insight on the mental impact of a cancer diagnosis on patients. Her studies and research showcased the importance of therapy and interventions to relieve anxiety and depression associated with cancer.
A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for Michael J. Hennessy Associates’ Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News®, Oncology Business Management™ and more. Michael J. Hennessy Associates, Inc. is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.
About Giants of Cancer Care:
Giants of Cancer Care celebrate the achievements of leading researchers and educators whose discoveries have helped propel the field forward and established the building blocks for future advances. In 2018, a selection committee of 100+ eminent oncologists, researches, and clinicians will choose honorees from several different tumor types and specialty categories.